China Health Care Stock Net Income
| CMIM Stock | USD 0.0002 0.00 0.00% |
China Health Care technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices.
China Health's financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing China Health's valuation are provided below:China Health Care does not presently have any fundamental signals for analysis. This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools. China |
China Health 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to China Health's pink sheet what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of China Health.
| 11/15/2025 |
| 02/13/2026 |
If you would invest 0.00 in China Health on November 15, 2025 and sell it all today you would earn a total of 0.00 from holding China Health Care or generate 0.0% return on investment in China Health over 90 days. China Health is related to or competes with Ridgestone Mining. Changming Industrial Management Group Holding provides hospital management consultancy services to VIP maternity and gyn... More
China Health Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure China Health's pink sheet current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess China Health Care upside and downside potential and time the market with a certain degree of confidence.
China Health Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for China Health's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as China Health's standard deviation. In reality, there are many statistical measures that can use China Health historical prices to predict the future China Health's volatility.China Health Care Backtested Returns
We have found three technical indicators for China Health Care, which you can use to evaluate the volatility of the firm. The firm shows a Beta (market volatility) of 0.0, which signifies not very significant fluctuations relative to the market. the returns on MARKET and China Health are completely uncorrelated.
Auto-correlation | 1.00 |
Perfect predictability
China Health Care has perfect predictability. Overlapping area represents the amount of predictability between China Health time series from 15th of November 2025 to 30th of December 2025 and 30th of December 2025 to 13th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of China Health Care price movement. The serial correlation of 1.0 indicates that 100.0% of current China Health price fluctuation can be explain by its past prices.
| Correlation Coefficient | 1.0 | |
| Spearman Rank Test | 1.0 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
Based on the recorded statements, China Health Care reported net income of (2.7 Million). This is 77.55% lower than that of the Basic Materials sector and significantly lower than that of the Other Industrial Metals & Mining industry. The net income for all United States stocks is 100.47% higher than that of the company.
China Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses China Health's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of China Health could also be used in its relative valuation, which is a method of valuing China Health by comparing valuation metrics of similar companies.China Health is currently under evaluation in net income category among its peers.
China Fundamentals
| Return On Asset | -0.73 | |||
| Operating Margin | (3.87) % | |||
| Current Valuation | 9.03 M | |||
| Shares Outstanding | 4.18 M | |||
| Price To Sales | 0.01 X | |||
| Revenue | 545.88 K | |||
| Gross Profit | 377.77 K | |||
| EBITDA | (1.31 M) | |||
| Net Income | (2.7 M) | |||
| Cash And Equivalents | 26.63 K | |||
| Cash Per Share | 0.01 X | |||
| Total Debt | 3.11 M | |||
| Current Ratio | 0.08 X | |||
| Book Value Per Share | (1.35) X | |||
| Cash Flow From Operations | (1.46 M) | |||
| Earnings Per Share | (0.29) X | |||
| Number Of Employees | 14 | |||
| Beta | 0.68 | |||
| Market Capitalization | 2.53 K | |||
| Total Asset | 1.5 M | |||
| Annual Yield | 0.12 % | |||
| Net Asset | 1.5 M |
About China Health Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze China Health Care's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of China Health using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of China Health Care based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Prophet is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ProphetOther Information on Investing in China Pink Sheet
China Health financial ratios help investors to determine whether China Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in China with respect to the benefits of owning China Health security.